Thermo Fisher Scientific Inc.

NYSE:TMO

Medical - Diagnostics & Research

Healthcare
$692.74 +0.96%

+$4.45 today

Market cap
$256.67B
Beta
0.87
P/E (TTM)
25.3
EPS (TTM)
$18.44
Dividend yield
0.39%
52W Low $390.50High $643.99

Volume 1.99M

Average 2.23M

TMO Pre-Tax Margin

Income before tax as a percentage of revenue.

Thermo Fisher Scientific Inc.NYSE: TMO

Pre-Tax Margin · Q3 FY2026 · quarter ended Sep 2026

Pre-tax margin widens to 17.2%

Pre-tax margin was 17.2% in Q3 FY2026, up 0.8 pp from a year earlier. On a trailing-twelve-month basis it was 16.6%, up 0.3 pp year over year. Over 3 fiscal years it narrowed by 0.8 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
17.2%+1.2 pp QoQ
Last fiscal yearDec 2025
16.3%-0.0 pp YoY
LTMSep 2026
16.6%+0.3 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.8 pp——
1 year-0.0 pp——
3 years-0.8 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
16.3%
Year-over-year change
-0.0pp

Pre-Tax Margin vs competitors

How TMO compares with its peers on the latest reported figures

  • TMO's LTM Sep 2026 pre-tax margin of 16.6% is the 6th highest of the 10 companies compared; the peer median is 18.5%.
  • Its year-over-year change of +0.3 pp is the 4th highest of 10, against a peer median of -2.0 pp.
  • Over three fiscal years its change of -0.8 pp compares with a peer median of -4.3 pp.
TMO Competitors Peer median
Pre-Tax Margin for TMO and competitors
Company Period LTM level YoY 3-year change
MTDMettler-Toledo International Inc.LTM Jun 202626.5% +0.1 pp-1.3 pp
AAgilent Technologies, Inc.LTM Jul 202622.5% +2.0 pp-1.3 pp
QGENQiagen N.V.LTM Jun 202622.0% -2.0 pp-0.5 pp
DHRDanaher CorporationLTM Sep 202618.8% +1.6 pp-9.6 pp
TECHBio-Techne CorporationLTM Sep 202618.5% +9.8 pp-10.0 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202616.6% +0.3 pp-0.8 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202613.5% -4.1 pp+206.4 pp
RVTYRevvity, Inc.LTM Jul 20269.0% -2.3 pp-10.3 pp
WATWaters CorporationLTM Jul 20264.4% -21.6 pp-4.3 pp
BRKRBruker CorporationLTM Jun 2026-0.8% -4.8 pp-15.8 pp
Peer median (excluding TMO) 18.5%-2.0 pp-4.3 pp

Competitors are the stored peer set for TMO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue39.21B44.92B42.86B42.88B44.56B
Cost of Revenue19.58B25.9B25.66B25.15B26.32B
Gross Profit19.63B19.01B17.19B17.73B18.24B
Gross Margin50.1%42.3%40.1%41.3%40.9%
Research & Development1.41B1.47B1.34B1.39B1.4B
Selling, General & Admin7.91B9.02B8.41B8.68B8.73B
Operating Expenses9.32B10.49B9.75B10.07B10.13B
Depreciation & Amortization2.59B3.38B3.41B3.11B2.78B
EBITDA11.97B11.94B11.2B11.8B11.47B
EBITDA Margin30.5%26.6%26.1%27.5%25.7%
Operating Income10.32B8.53B7.45B7.66B8.11B
Operating Margin26.3%19.0%17.4%17.9%18.2%
Interest Income43M272M879M1.08B993M
Interest Expense536M726M1.49B1.65B1.42B
Other Income / Expenses(1.48B)(862M)(1.21B)(667M)(842M)
Income Before Tax8.84B7.66B6.24B7B7.27B
Pre-Tax Margin22.5%17.1%14.6%16.3%16.3%
Income Tax Expense1.11B703M284M657M547M
Net Income7.73B6.95B6B6.34B6.74B
Net Margin19.7%15.5%14.0%14.8%15.1%
EPS (Basic)19.6117.7315.5316.5817.77
EPS (Diluted)19.4617.6415.4516.5317.74
Weighted Avg Shares394M392M386M382M376M
Weighted Avg Shares (Diluted)397M394M388M383M377M

Thermo Fisher Scientific Inc.

NYSE:TMO

Intrinsic Alpha fair value

Locked

Current Price

$692.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.